James L. Cunniff bought $137k of ELMD
CEO and President at Electromed, Inc.. 9,000 shares at an average of $15.25, traded Mar 1, 2024, filed Mar 5, 2024.
Score components
- +25RoleCEO
- +11Trade size$137k at market
- +10Relative to holdingsHoldings up 900%
- 0Price contextNear the top of the 52-week range
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-24-006646, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 1, 2024 | POpen-market purchase Common Stock | +9,000 | $15.25 | $137k | 10,000 | Mar 5, 2024 |
Related signals
Other insiders at Electromed, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | Electromed, Inc. | James L. Cunniff CEO and President | $354k 9,700 shares | -6% | |
| 42Moderate | Electromed, Inc. | Bradley M. Nagel Chief Financial Officer | $429k 11,801 shares | -38% | |
| 45Moderate | ELMDsell Electromed, Inc. | Kathleen Skarvan director | $1.4M 40,000 shares | -53% | |
| 60Notable | ELMDsell Electromed, Inc. | Andrew Summers director | $1.6M 65,714 shares | -100% | |
| 58Moderate | Electromed, Inc. | Andrew Summers director | $3.1M 111,475 shares | -37% | |
| 63Notable | Electromed, Inc. | Kathleen Skarvan director | $2.3M 76,583 shares | -95% | |
| 45Moderate | ELMDsell Electromed, Inc. | Andrew Summers director | $1.1M 37,404 shares | -12% | |
| 53Moderate | Electromed, Inc. | Andrew Summers director | $2.0M 65,630 shares | -19% | |
| 78Notable | Electromed, Inc. | Kathleen Skarvan director | $4.2M 150,000 shares | -103% | |
| 36Weak | ELMDbuy Electromed, Inc. | Andrew Summers director | $302k 28,797 shares | +9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.